| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/28/2002 | WO2002009667A9 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/28/2002 | WO2002000269A8 The use of honey in wound dressings |
| 02/28/2002 | WO2001093853B1 Management of snoring by oral administration of dimethyl sulfone |
| 02/28/2002 | WO2001087236A3 Topical administration of pharmacological compositions for non-systemic treatment of pruritus |
| 02/28/2002 | WO2001083385A3 Devices and method for production of traceable immunizing drinking water, other liquids and gas |
| 02/28/2002 | WO2001072281A3 Microspheres for active embolization |
| 02/28/2002 | WO2001070224A3 Rilmenidine dressing and method for preparing same |
| 02/28/2002 | WO2001066084A3 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| 02/28/2002 | WO2001064254A3 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 02/28/2002 | WO2001062217A3 Oil-based cosmetics containing water-soluble actives |
| 02/28/2002 | WO2001060998A3 Small oligonucleotides with anti-tumor activity |
| 02/28/2002 | WO2001051090A3 Amphilic and ionic polymer matrixes and derivatives thereof |
| 02/28/2002 | WO2001045661A3 Cosmetic and/or pharmaceutical preparations |
| 02/28/2002 | WO2001041776B1 Use of honey in medical dressings |
| 02/28/2002 | WO2001036656B1 A complex between hyaluronic acid and a biomolecule and its use |
| 02/28/2002 | WO2001024804A3 Method for preparing a composition by mother-of-pearl extraction, and use thereof in cosmetics and dermatology |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | WO2001015755A3 Methods and compositions for delivery of pharmaceutical agents |
| 02/28/2002 | US20020026236 Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia |
| 02/28/2002 | US20020026176 Devices for intraocular drug delivery |
| 02/28/2002 | US20020026158 Synchronising of animal oestrus and intra vaginal devices useful therein |
| 02/28/2002 | US20020026038 Slurrying a solid comprising clarithromycin Form 0 in water; macrolide antibiotic related to erythromycin A |
| 02/28/2002 | US20020026027 Polyamide oligomers |
| 02/28/2002 | US20020025984 Tablets, capsules |
| 02/28/2002 | US20020025981 Synergistic mixture of amlodipine and statins |
| 02/28/2002 | US20020025980 Single morphic forms of metalloproteinase inhibitors |
| 02/28/2002 | US20020025979 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/28/2002 | US20020025978 Veterinary medicine |
| 02/28/2002 | US20020025964 In cellulose binder; bioavailability, storage stability |
| 02/28/2002 | US20020025953 Using oil |
| 02/28/2002 | US20020025946 Acylated cyclodextrin: guest molecule inclusion complexes |
| 02/28/2002 | US20020025927 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 02/28/2002 | US20020025911 Active carbon; removal toxic compounds by adsorption |
| 02/28/2002 | US20020025578 Intensified expression of nucleotide sequences in mammal; administer nucleic acids to mammal, transfect nucleotide sequence using voltage, monitor mammal for gene expression |
| 02/28/2002 | US20020025562 Plasma-like solution |
| 02/28/2002 | US20020025350 Dietary supplements |
| 02/28/2002 | US20020025344 As antimicrobial agent |
| 02/28/2002 | US20020025342 Novel administration form comprising an acid-labile active compound |
| 02/28/2002 | US20020025341 Controlled release formulation of divalproex sodium |
| 02/28/2002 | US20020025339 Antidepressant, sustained release, for controlling blood plasma level of durg venlafaxine hydrochloride |
| 02/28/2002 | US20020025338 Bioavailable dosage form of isotrentinoin |
| 02/28/2002 | US20020025337 Lipid vehicle drug delivery composition containing vitamin e |
| 02/28/2002 | US20020025334 Protective barrier composition |
| 02/28/2002 | US20020025329 For immunization |
| 02/28/2002 | US20020025327 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 02/28/2002 | US20020025326 Delivery vehicle composition and methods for delivering antigens and other drugs |
| 02/28/2002 | US20020025325 Mixing a water soluble palatable flavorant with a water soluble vehicle for administration of an orally administered vaccine admixing with an antigen selected from bacterium and a virus as an active component; administering to animal |
| 02/28/2002 | US20020025313 Targeting of liposomes to the blood-brain barrier |
| 02/28/2002 | US20020025300 Edible herbal compositions for relieving nicotine craving |
| 02/28/2002 | US20020025299 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 02/28/2002 | DE10040174A1 Treatment of coccidiosis comprises administration of haloalkylsulfonyl substituted phenoxyphenyl-triazinetrione derivatives |
| 02/28/2002 | DE10040110A1 Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen Use of triazinetrione sulfoxides to combat coccidioses |
| 02/28/2002 | CA2425206A1 Treatment of trauma, and other indications |
| 02/28/2002 | CA2420194A1 Use of a porous carrier |
| 02/28/2002 | CA2420190A1 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2419597A1 Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading |
| 02/28/2002 | CA2419592A1 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2418730A1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2415349A1 Testosterone ester formulation for human use |
| 02/28/2002 | CA2356058A1 Intermittent administration of a growth hormone secretagogue |
| 02/27/2002 | EP1182194A1 Pernasal preparations |
| 02/27/2002 | EP1181983A2 Spray gun for enteric coating and process for producing enteric coated preparation |
| 02/27/2002 | EP1181932A2 Therapeutic compositions comprising excess enantiomer of amlodipine |
| 02/27/2002 | EP1181931A2 Intraoral adhesive preparation |
| 02/27/2002 | EP1181930A1 Patch |
| 02/27/2002 | EP1181929A2 Method of potentiating an immune response and compositions therefor |
| 02/27/2002 | EP1181928A1 Microliposomes and process for producing the same |
| 02/27/2002 | EP1181911A1 Steam generating cell with adhesive application layer |
| 02/27/2002 | EP1181363A1 Recombinant human mannan-binding lectin |
| 02/27/2002 | EP1181323A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 02/27/2002 | EP1181312A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 02/27/2002 | EP1181302A1 Orally active a1 adenosine receptor agonists |
| 02/27/2002 | EP1181190A1 Method and apparatus for loading a container with a product |
| 02/27/2002 | EP1181057A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 02/27/2002 | EP1181042A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area |
| 02/27/2002 | EP1181040A1 Compositions of a-beta peptide and processes for producing same |
| 02/27/2002 | EP1181038A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/27/2002 | EP1181036A1 Pharmaceutical compositions of erythropoietin |
| 02/27/2002 | EP1181035A2 Substantially oil-free cyclosporin compositions |
| 02/27/2002 | EP1181034A2 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 02/27/2002 | EP1181029A1 Balsam for the treatment of surface burns and chafing rashes |
| 02/27/2002 | EP1181027A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 02/27/2002 | EP1181023A1 Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
| 02/27/2002 | EP1181018A1 Ziprasidone suspension |
| 02/27/2002 | EP1181015A2 Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| 02/27/2002 | EP1181010A1 Pharmaceutical chewing gum formulations |
| 02/27/2002 | EP1181009A1 Method of producing submicron particles of a labile agent |
| 02/27/2002 | EP1181001A2 Sunscreen composition containing sol-gel microcapsules |
| 02/27/2002 | EP1180994A1 Method and device for producing a product made of strip tape, especially a medical product and/or a product containing active substances as well as fillable receptacles or pouches whose edges can be sealed |
| 02/27/2002 | EP1180944A1 Compositions containing creatine in suspension |
| 02/27/2002 | EP1180937A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 02/27/2002 | EP1107823B1 Method for treating a particulate material with a coating substance and device for implementing such a method |
| 02/27/2002 | EP1027034B1 Marker for intestinal diagnosis and intestinal therapy |
| 02/27/2002 | EP1003559B1 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/27/2002 | EP0977780A4 NOVEL HETERO-POLYSACCHARIDE CONJUGATES, NOVEL s-INP POLYSACCHARIDE GELS AND METHODS OF MAKING AND USING THE SAME |
| 02/27/2002 | EP0946156B1 Drinkable ibuprofen composition |
| 02/27/2002 | EP0939626B1 Galenic formula with extended release of milnacipran |
| 02/27/2002 | EP0939623B1 Oral delayed immediate release formulation and method of preparation therefor |
| 02/27/2002 | EP0917460B1 Cyclosporin formulation |
| 02/27/2002 | EP0914127B1 Antifungal composition with enhanced bioavailability |